Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q8TBE9
UPID:
NANP_HUMAN
Alternative names:
Haloacid dehalogenase-like hydrolase domain-containing protein 4; Neu5Ac-9-Pase
Alternative UPACC:
Q8TBE9; B3KP12; Q5JYN8; Q8TE97; Q9Y3N0
Background:
N-acylneuraminate-9-phosphatase, also known by its alternative names Haloacid dehalogenase-like hydrolase domain-containing protein 4 and Neu5Ac-9-Pase, plays a crucial role in the metabolism of sialic acids, which are key components of cell membranes and are involved in cellular communication and pathogen recognition. This protein's enzymatic activity is pivotal in the catabolism of sialic acids, facilitating their recycling within the cell.
Therapeutic significance:
Understanding the role of N-acylneuraminate-9-phosphatase could open doors to potential therapeutic strategies. Its involvement in the metabolism of sialic acids, crucial for cellular communication, suggests that modulating its activity could have implications for diseases where cell signaling is disrupted.